Related Experiment Video
Updated: Jun 2, 2026

10:04
Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
Tuberculosis mortality trends in cuba, 1998 to 2007
Edilberto González1, Grisel E Risco, Susana Borroto
1Pedro Kourí Institute of Tropical Medicine, Havana, Cuba. ochoa@ipk.sld.cu.
MEDICC Review
|April 13, 2011
Summary
Tuberculosis (TB) mortality in Cuba significantly decreased by 2007, meeting the World Health Organization
Area of Science:
- Public Health
- Epidemiology
- Infectious Disease Research
Background:
- Tuberculosis (TB) remains a significant global health challenge.
- The World Health Organization (WHO) set a target to halve TB mortality by 2015.
- Cuba has historically shown a declining trend in TB mortality.
Purpose of the Study:
- To analyze TB mortality trends in Cuba from 1998 to 2007.
- To examine TB mortality by infection site, sex, age, and province.
- To assess progress towards the WHO's 2015 TB mortality reduction target.
Main Methods:
- Ecological time series study design.
- Utilized death certificate data for TB as cause of death.
- Analyzed population data by age, sex, and province.
Main Results:
- TB mortality dropped from 0.4 to 0.2 per 100,000 population between 1998 and 2007.
- Both pulmonary and extrapulmonary TB mortality rates decreased.
- Higher mortality rates observed in males, individuals aged 65+, and in Havana province.
Conclusions:
- Cuba achieved the WHO's 2015 TB mortality reduction target ahead of schedule.
- TB mortality declined steadily relative to overall and infectious disease deaths.
- Continued trends suggest TB may become an exceptional cause of death in Cuba.
Related Concept Videos
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
